Cellistic

Cellistic is the iPSC-first CDMO making cell therapies mainstream. From cell line development to GMP manufacturing, Cellistic helps bring iPSC-derived cell therapy and regenerative medicine to clinic and scale. With 15+ years of exclusive iPSC focus, industrialized technology platforms, and flexible partnering models, the company offers an integrated and proven path forward – helping innovators move faster, reduce risk, and turn promising programs into scalable therapies.

For more information: visit Cellistic.com